TīmeklisByfavo is a medicine that contains the active substance remimazolam. Remimazolam is one of a group of substances known as benzodiazepines. Byfavo is a sedative given before a medical test or procedure to make you feel relaxed and sleepy (sedated). 2. What you need to know before you are given Byfavo You must not be given Byfavo if: TīmeklisAn SmPC is based on clinical trials that a pharmaceutical company has carried out, and gives information about dose, use and possible side effects. An SmPC is always written in a standard format, which is explained in our glossary. Patient Information Leaflets. A PIL is the leaflet that is included in the pack with a medicine. The PIL is a ...
BILAG I PRODUKTRESUMÉ - European Medicines Agency
TīmeklisRemimazolam administered under the supervision of a pulmonologist was effective and safe for moderate sedation during flexible bronchoscopy. In an exploratory analysis, … Tīmeklis2024. gada 24. febr. · Oxaliplatin 5 mg/ml concentrate for solution for infusion - Summary of Product Characteristics (SmPC) - (emc) Oxaliplatin 5 mg/ml concentrate for solution for infusion Active Ingredient: oxaliplatin Company: Ranbaxy (UK) Limited a Sun Pharmaceutical Company See contact details About Medicine Prescription … corresponding footnote
Remimazolam: pharmacological characteristics and clinical …
Tīmeklis2024. gada 3. apr. · Die Zulassung für Remimazolam basiert auf Daten aus einem umfassenden klinischen Programm in der Allgemeinanästhesie. Darin konnte u.a. eine geringere Inzidenz hämodynamischer Nebenwirkungen im Vergleich zu Propofol gezeigt werden. Remimazolam wurde bereits in Japan und in Südkorea für die … Tīmeklis2024. gada 13. apr. · Background Remimazolam is a new short-duration anesthetic currently used for gastroscopy and can be mixed with propofol and potent opioids. … TīmeklisThe pharmacokinetics and pharmacodynamics of remimazolam are characterized by relatively high clearance, small steady-state volume of distribution, short elimination … corresponding index